Hematologic Malignancy: Clinical Trials

3 trials for Hematologic Malignancy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 21Completed 1

Follow Hematologic Malignancy: new trials by email Literature Review of Hematologic Malignancy trials Research Report on Hematologic Malignancy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Expressive Helping for Stem Cell Transplant Patients
Expressive Helping, Factual Writing - Stem Cell Transplantation, Hematologic Malignancy
Phase 3CompletedNorthwestern University4052019-03-062023-05-06
Efficacy of Prophylactic Low Level Laser Therapy (LLLT) Performed by Nurses for Decreasing Severity of Oral Mucositis During Hematopoietic Stem Cell (HSC) Transplantation
Laser treatment, Placebo - Hematologic Malignancy
Phase 3CompletedInstitut de Cancérologie de la Loire2342016-06-272020-01-29
Mindfulness Meditation in Bone Marrow Transplantation
Mindfulness training, Nurse education - Hematologic Malignancy, Bone Marrow Transplantation
Phase 2 / Phase 3CompletedEmory University2412005-04-012013-11-28

Narrower conditions

Hematologic Neoplasms (3)  ·  Mucositis (1)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Digestive System Diseases (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Mouth Diseases (1)  ·  Stomatognathic Diseases (1)

Interventions

Laser Therapy (1)

Sponsors

Emory University (1)  ·  Institut de Cancérologie de la Loire (1)  ·  Northwestern University (1)

Countries

United States (2)  ·  France (1)

Top investigators

Susan Bauer-Wu, PhD (1)

Results publications

PMID 34670600

NIH funding

R01CA223963 (1)